These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37668235)

  • 1. [KIF1A gene-associated neurological disease: the correlation between genotype and phenotype].
    Ortiz-Ortigosa A; Calvo-Medina R; Ruiz-García C; Vera-Medialdea R; Ramos-Fernández JM
    Rev Neurol; 2023 Sep; 77(6):141-145. PubMed ID: 37668235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of comprehensive clinical phenotype and longitudinal adaptive function and correlation with computational predictions of severity of missense genotypes in KIF1A-associated neurological disorder.
    Sudnawa KK; Li W; Calamia S; Kanner CH; Bain JM; Abdelhakim AH; Geltzeiler A; Mebane CM; Provenzano FA; Sands TT; Fee RJ; Montes J; Shen Y; Chung WK
    Genet Med; 2024 Aug; 26(8):101169. PubMed ID: 38785164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemorrhagic shock and encephalopathy syndrome in a patient with a de novo heterozygous variant in KIF1A.
    Isobe K; Ieda D; Miya F; Miyachi R; Otsuji S; Asai M; Tsunoda T; Kosaki K; Hattori A; Saitoh S; Mizuno M
    Brain Dev; 2022 Mar; 44(3):249-253. PubMed ID: 34916088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo mutations in the motor domain of KIF1A cause cognitive impairment, spastic paraparesis, axonal neuropathy, and cerebellar atrophy.
    Lee JR; Srour M; Kim D; Hamdan FF; Lim SH; Brunel-Guitton C; Décarie JC; Rossignol E; Mitchell GA; Schreiber A; Moran R; Van Haren K; Richardson R; Nicolai J; Oberndorff KM; Wagner JD; Boycott KM; Rahikkala E; Junna N; Tyynismaa H; Cuppen I; Verbeek NE; Stumpel CT; Willemsen MA; de Munnik SA; Rouleau GA; Kim E; Kamsteeg EJ; Kleefstra T; Michaud JL
    Hum Mutat; 2015 Jan; 36(1):69-78. PubMed ID: 25265257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIF1A mutation in a patient with progressive neurodegeneration.
    Okamoto N; Miya F; Tsunoda T; Yanagihara K; Kato M; Saitoh S; Yamasaki M; Kanemura Y; Kosaki K
    J Hum Genet; 2014 Nov; 59(11):639-41. PubMed ID: 25253658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of the phenotypic spectrum of de novo missense variants in kinesin family member 1A (KIF1A).
    Kaur S; Van Bergen NJ; Verhey KJ; Nowell CJ; Budaitis B; Yue Y; Ellaway C; Brunetti-Pierri N; Cappuccio G; Bruno I; Boyle L; Nigro V; Torella A; Roscioli T; Cowley MJ; Massey S; Sonawane R; Burton MD; Schonewolf-Greulich B; Tümer Z; Chung WK; Gold WA; Christodoulou J
    Hum Mutat; 2020 Oct; 41(10):1761-1774. PubMed ID: 32652677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant transmission of de novo KIF1A motor domain variant underlying pure spastic paraplegia.
    Ylikallio E; Kim D; Isohanni P; Auranen M; Kim E; Lönnqvist T; Tyynismaa H
    Eur J Hum Genet; 2015 Oct; 23(10):1427-30. PubMed ID: 25585697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterozygous
    Nicita F; Ginevrino M; Travaglini L; D'Arrigo S; Zorzi G; Borgatti R; Terrone G; Catteruccia M; Vasco G; Brankovic V; Siliquini S; Romano S; Veredice C; Pedemonte M; Armando M; Lettori D; Stregapede F; Bosco L; Sferra A; Tessarollo V; Romaniello R; Ristori G; Bertini E; Valente EM; Zanni G
    J Med Genet; 2021 Jul; 58(7):475-483. PubMed ID: 32737135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Observation of a Japanese Patient with a Multiple-system Neurodegenerative Disorder with a Uniallelic de novo Missense Variant in KIF1A.
    Nakamura K; Yoshinaga T; Kodaira M; Kise E; Kosho T; Sekijima Y
    Intern Med; 2023 Oct; 62(20):3047-3051. PubMed ID: 36889712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo mutations in KIF1A-associated neuronal disorder (KAND) dominant-negatively inhibit motor activity and axonal transport of synaptic vesicle precursors.
    Anazawa Y; Kita T; Iguchi R; Hayashi K; Niwa S
    Proc Natl Acad Sci U S A; 2022 Aug; 119(32):e2113795119. PubMed ID: 35917346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A de novo dominant mutation in KIF1A associated with axonal neuropathy, spasticity and autism spectrum disorder.
    Tomaselli PJ; Rossor AM; Horga A; Laura M; Blake JC; Houlden H; Reilly MM
    J Peripher Nerv Syst; 2017 Dec; 22(4):460-463. PubMed ID: 28834584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo mutations in KIF1A cause progressive encephalopathy and brain atrophy.
    Esmaeeli Nieh S; Madou MR; Sirajuddin M; Fregeau B; McKnight D; Lexa K; Strober J; Spaeth C; Hallinan BE; Smaoui N; Pappas JG; Burrow TA; McDonald MT; Latibashvili M; Leshinsky-Silver E; Lev D; Blumkin L; Vale RD; Barkovich AJ; Sherr EH
    Ann Clin Transl Neurol; 2015 Jun; 2(6):623-35. PubMed ID: 26125038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autosomal dominant neurodevelopmental disorders associated with
    Lin J; Li N; Yao R; Yu T; Wang X; Wang J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 52(6):693-700. PubMed ID: 38105687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autosomal dominant transmission of complicated hereditary spastic paraplegia due to a dominant negative mutation of KIF1A, SPG30 gene.
    Cheon CK; Lim SH; Kim YM; Kim D; Lee NY; Yoon TS; Kim NS; Kim E; Lee JR
    Sci Rep; 2017 Oct; 7(1):12527. PubMed ID: 28970574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo KIF1A mutations cause intellectual deficit, cerebellar atrophy, lower limb spasticity and visual disturbance.
    Ohba C; Haginoya K; Osaka H; Kubota K; Ishiyama A; Hiraide T; Komaki H; Sasaki M; Miyatake S; Nakashima M; Tsurusaki Y; Miyake N; Tanaka F; Saitsu H; Matsumoto N
    J Hum Genet; 2015 Dec; 60(12):739-42. PubMed ID: 26354034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoallelic KIF1A-related disorders: a multicenter cross sectional study and systematic literature review.
    Vecchia SD; Tessa A; Dosi C; Baldacci J; Pasquariello R; Antenora A; Astrea G; Bassi MT; Battini R; Casali C; Cioffi E; Conti G; De Michele G; Ferrari AR; Filla A; Fiorillo C; Fusco C; Gallone S; Germiniasi C; Guerrini R; Haggiag S; Lopergolo D; Martinuzzi A; Melani F; Mignarri A; Panzeri E; Pini A; Pinto AM; Pochiero F; Primiano G; Procopio E; Renieri A; Romaniello R; Sancricca C; Servidei S; Spagnoli C; Ticci C; Rubegni A; Santorelli FM
    J Neurol; 2022 Jan; 269(1):437-450. PubMed ID: 34487232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insight into the regulation of axonal transport from the study of KIF1A-associated neurological disorder.
    Chiba K; Kita T; Anazawa Y; Niwa S
    J Cell Sci; 2023 Mar; 136(5):. PubMed ID: 36655764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variants in KIF1A gene in dominant and sporadic forms of hereditary spastic paraparesis.
    Citterio A; Arnoldi A; Panzeri E; Merlini L; D'Angelo MG; Musumeci O; Toscano A; Bondi A; Martinuzzi A; Bresolin N; Bassi MT
    J Neurol; 2015 Dec; 262(12):2684-90. PubMed ID: 26410750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Novel KIF1A Missense Variant (R169T) Strongly Reduces Microtubule Stimulated ATPase Activity and Is Associated With NESCAV Syndrome.
    Aguilera C; Hümmer S; Masanas M; Gabau E; Guitart M; Jeyaprakash AA; Segura MF; Santamaria A; Ruiz A
    Front Neurosci; 2021; 15():618098. PubMed ID: 34121983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizures.
    Howell KB; McMahon JM; Carvill GL; Tambunan D; Mackay MT; Rodriguez-Casero V; Webster R; Clark D; Freeman JL; Calvert S; Olson HE; Mandelstam S; Poduri A; Mefford HC; Harvey AS; Scheffer IE
    Neurology; 2015 Sep; 85(11):958-66. PubMed ID: 26291284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.